Comparison of ceftriaxone and cefotaxime in severe pediatric bacterial infection: A multicentric study;Evaluation de la ceftriaxone et du cefotaxime dans l'infection bacterienne severe en pediatrie: Etude multicentrique

Medecine et Maladies Infectieuses

Volumn 28, Issue 4, 1998, Pages 300-306

  Begue, P ^a   Astruc, J ^a   Francois, P ^a   Floret, D ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Ceftriaxone; Health care cost; Pediatric; Severe infections; Third generation cephalosporin

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CEFOTAXIME; CEFTRIAXONE; IMIDAZOLE DERIVATIVE;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENTEROBACTER; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEISSERIA MENINGITIDIS; NEWBORN; PEDIATRICS; PROTEUS MIRABILIS; PSEUDOMONAS; SALMONELLA TYPHI; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0031745819     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-077x(98)80054-1     Document Type: Article

References (22)

1. Martin E. Koup J. Paravicini U. Stoeckel K. Pharmacokinetic of ceftriaxone in neonates and infants with meningitis J Pediatr 105 1984 475 481
2. HS Bégué P. Place de la ceftriaxone dans le traitement des infections de l'enfant Méd Mal Infect 19 1989 101 106
3. Goldstein F. Le quotient inhibiteur: un élément décisif dans le choix de la ceftriaxone Lettre Pharmacol 6 1992 228 230
4. Albertini M. Garraffo R. Drugeon H.B. Mariani R. Lapalus P. Pharmacokinetics and bacteriological activity of i.v. ceftriaxone administered to children as a single daily infusion of 50 mg/kg Inter J Exp Clin Chemoth 5 1992 125 133
5. Denis F. Cadoz M. Diop Mar I. Ceftriaxone concentrations in cerebral fluid of patients with purulent meningitis Proceding of the 13th International Congres of Chemotherapie 7 1983 122/1 122/3
6. Steele R.W. Bradsher R.W. Comparison of ceftriaxone with standard therapy for bacterial meningitis J Pediatr 103 1983 138 141
7. Congeni B.L. Comparison of ceftriaxone and traditional therapy of bacterial meningitis Antimicrob Agents Chemother 25 1984 40 44
8. Chadwick E.G. Connor E.M. Shulman S.T. Yogev R. Efficacy of ceftriaxone in treatment of serious childhood infections J Pediatr 103 1983 141 145
9. Congeni B.L. Bradley J. Hammerschlag M.R. Safety and efficacy of once daily ceftriaxone for the treatment of bacterial meningitis Pediatr Infect Dis J 5 1986 293 297
10. Congeni B.L. Chonmaitree T. Rakusan T.A. Box Q.T. Once daily ceftriaxone therapy for serious bacterial infections in children Antimicrob Agents Chemother 27 1985 181 183
11. Dagan R. Phillip M. Watemberg N.M. Kassis I. Outpatient treatment of serious community acquired infections using once daily intramuscular ceftriaxone Pediatr Infect Dis J 6 1987 1080 1084
12. Mc Closkey R.V. Harvey G. Wilson D. A. Perceval T. Kelly Once daily dosage: the clinical view. “Changing concepts in antibiotic therapy five year's experience with ceftriaxone” 1988 Gardiner-Caldwell communications LTD Macclesfield UK
13. Peltola H. Anttila M. Renkonen O.V. Randomised comparison of chloramphenicol, ampicillin, cefotaxime and ceftriaxone for childhood bacterial meningitis Lancet 1 1989 1281 1287
14. Gaillard J.L. Abadie V. Cheron G. Concentration of ceftriaxone in cerebrospinal fluid of children with meningitis receiving dexamethasone therapy Antimicrob Agents Chemother 38 1994 1209 1210
15. Shaad U.B. Mc Cracken G.H. Look C.A. Thomas M.L. Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone and rocephin in experimental bacterial meningitis J Infect Dis 143 1981 156 163
16. Mc Cracken G.H. Nelson J.D. Kaplan S.L. Overturf G.D. Rodriguez W.J. Steele R.W. Consensus report, antimicrobial therapy for bacterial meningitis in infants and children Pediatr Infect Dis J 6 1987 501 505
17. Schaad U.B. Wedcwood-Krucko J. Tschaeppeler H. Reversible ceftriaxone-associated biliary pseudolithiasis in children Lancet 2 1988 1411 1413
18. HS Quinet B. Bégué P. Ceftriaxone et méningites en pédiatrie Méd Mal Infect 19 1989 96 100
19. Levy E. Ceftriaxone: the economics of once daily treatment Insights into the treatment of serious infections 2 1988 198 202
20. Steele R. Cost considerations in the treatment of pediatric infectious diseases Economics of ceftriaxone use Proceedings of a Workshop 14th International Congress of Chemotherapy, Kyoto 1985 31 36
21. Huchet J. Pihouée Ph. Coût de traitement comparé dans les infections sévères de deux céphalosporines de 3e génération Pharm Hospit 98 1989 27 35
22. Kaplan J.M. Goretski S.A. Keith S.H. Calford L. Cost of antibiotic therapy for infants and children Pediatr Infect Dis J 9 1990 722 728